Product image of Metronidazole Noridem (Metronidazole) supplied by GNH India

Metronidazole Noridem

Active Ingredient:
Metronidazole
Origin:
EU

Metronidazole Noridem (Metronidazole)

Metronidazole, the active ingredient in Metronidazole Noridem, is a nitroimidazole presented as an intravenous formulation for IV use. It treats anaerobic bacterial infections and related conditions in adult patients.
GNH India supplies Metronidazole Noridem as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Manufacturer / TM Owner

Noridem Enterprises Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metronidazole Noridem is used to treat infections caused by anaerobic organisms and related protozoal diseases.

  • Anaerobic bacterial infections: eradicates susceptible anaerobes and reduces infection severity.
  • Bacterial vaginosis: restores normal vaginal flora by eliminating over‑growth of anaerobic bacteria.
  • Trichomoniasis: eliminates Trichomonas vaginalis, relieving symptoms and preventing recurrence.
  • Amebic liver abscess: destroys Entamoeba histolytica trophozoites, aiding resolution of hepatic lesions.
  • Clostridioides difficile infection: suppresses toxin‑producing C. difficile, helping resolve colitis.

How It Works

  • Metronidazole is taken up by anaerobic cells where it is reduced to reactive nitro radicals. These radicals damage DNA and inhibit nucleic acid synthesis, leading to loss of cell viability and bacterial or protozoal death. The selective reduction occurs primarily in low‑oxygen environments, sparing aerobic host tissues.

Side Effects

Metronidazole Noridem may cause a range of adverse reactions.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Metallic taste: transient metallic sensation in the mouth.
  • Headache: mild to moderate headache.
  • Dizziness: occasional light‑headedness.
  • Diarrhea: loose stools.
  • Abdominal pain: cramping or discomfort.

Serious or Rare Side Effects

  • Seizures: rare neurologic events.
  • Peripheral neuropathy: tingling or numbness in extremities.
  • Stevens‑Johnson syndrome: severe skin reaction.
  • Severe allergic reactions: rash, swelling, or anaphylaxis.
  • Hepatic toxicity: elevated liver enzymes or hepatitis.
  • Pancytopenia: reduced blood cell counts.

Precautions & Warnings

Before using Metronidazole Noridem, consider the following safety measures.

  • Renal function assessment: adjust therapy if renal impairment is present.
  • Hepatic monitoring: check liver enzymes during prolonged treatment.
  • Alcohol avoidance: prevent disulfiram‑like reaction.
  • Pregnancy caution: evaluate risk‑benefit, use only if clearly needed.
  • Hypersensitivity evaluation: discontinue if allergic reaction occurs.
  • Store at ambient temperature: keep in original container, protect from light and moisture.

Avoid Interactions

Metronidazole Noridem can interact with several medicines; awareness helps avoid adverse outcomes.

Major Interactions (Avoid)

  • Alcohol: may cause severe flushing and vomiting.
  • Warfarin: increased anticoagulant effect, risk of bleeding.
  • Lithium: heightened lithium toxicity.
  • Cytochrome P450 inducers (e.g., phenytoin, carbamazepine): reduce metronidazole levels.
  • Disulfiram: additive disulfiram‑like reaction.

Moderate Interactions (Monitor Closely)

  • Cimetidine: may raise metronidazole concentrations.
  • Oral contraceptives: possible reduction in efficacy.
  • Rifampin: may lower metronidazole exposure.
  • Theophylline: potential increase in theophylline levels.
  • Anticonvulsants (e.g., phenobarbital): may modestly decrease metronidazole effectiveness.

Frequently Asked Questions

Metronidazole Noridem is indicated for treating anaerobic bacterial infections, bacterial vaginosis, trichomoniasis, amebic liver abscess, and Clostridioides difficile infection. It is administered intravenously to patients who require rapid systemic exposure to the drug.

Metronidazole enters anaerobic microorganisms and is reduced to nitro radicals. These reactive species damage DNA and inhibit nucleic acid synthesis, leading to cell death. The reduction process occurs preferentially in low‑oxygen environments, targeting pathogenic bacteria and protozoa while sparing most human cells.

The specific dose and infusion rate of Metronidazole Noridem are determined by the prescribing clinician based on the infection type, severity, patient weight, renal and hepatic function, and other clinical factors. Healthcare providers set the regimen according to approved guidelines.

Safety data for Metronidazole Noridem in pregnancy are limited, and the drug should be used only if the potential benefit justifies any potential risk to the fetus. It is excreted in breast milk, so breastfeeding mothers should discuss risks with their healthcare professional before use.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Metronidazole is a nitroimidazole that specifically targets anaerobic organisms, offering rapid bactericidal activity. Compared with broad‑spectrum agents like clindamycin or carbapenems, metronidazole provides a narrower spectrum focused on anaerobes, often resulting in fewer disruptions to normal flora and a distinct safety profile.

Metronidazole Noridem should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and extreme temperature fluctuations to maintain stability.

The medication is given intravenously by a healthcare professional. It is typically infused over a specified period, as directed by the prescriber, to ensure appropriate plasma concentrations and therapeutic effect.

Serious adverse events include seizures, peripheral neuropathy, severe allergic reactions such as Stevens‑Johnson syndrome, hepatic toxicity, and pancytopenia. Patients should be monitored for neurological symptoms, liver function changes, and any signs of hypersensitivity during therapy.

Individuals with a known hypersensitivity to metronidazole or other nitroimidazoles should avoid the product. Caution is also advised for patients with severe hepatic impairment, those consuming alcohol, and patients for whom the risk–benefit ratio is unfavorable, such as certain pregnant women.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metronidazole

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT